Israeli-founded biotech exits for $11.9 billion
US giant Gilead has just bought Kite (a biotech founded by Israel’s Arie Belldegrun) for $11.9 billion. Kite’s CAR-T technology was developed by Weizmann Institute’s Professor Zelig Eshhar. A patient’s own immune system T-cells are genetically engineered to attack tumors.
This entry was posted in Economy & Business
. Bookmark the permalink